Correlation Analysis
Regeneron Pharmaceuticals Inc vs VISA Inc.
REGN vs V
+0.015
Near-zero positive
When one moves up, the other tends to follow.
Regeneron Pharmaceuticals Inc
↗REGN
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has early-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).
Market cap 80.7B · 15,410 employees
VISA Inc.
↗V
Visa is the largest payment processor in the world. In fiscal 2025, it processed almost $17 trillion in total volume. Visa operates in over 200 countries and processes transactions in over 160 currencies. Its systems are capable of processing over 65,000 transactions per second.
Market cap 583.4B
Time Series
Relative Performance
Who Moves First
REGN leads V by 6 days
REGN tends to move before V.
After testing 13 timing shifts, the strongest relationship was +0.020 (they moved in the same direction).
Do They Crash Together?
Correlation by Market Regime
How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.
Both Rising
-0.090
13 periods · Return correlation when both series rose
Both Falling
-0.029
9 periods · Return correlation when both series fell
Diverging
-0.638
13 periods · Return correlation when series moved apart
R-Squared
0.0%
Share of variance in one series explained by the other.
Trend Agreement
60.5%
How often both series moved in the same direction period-to-period.
Overlap Quality
1,254
Deep shared window — 1,254 usable pairs.
Significance
n.s.
95% CI: [-0.041, 0.070]
Scatter
XY Regression
Pipeline
Data quality details
Pipeline
Data quality details
Pipeline Summary
1,254 paired data points survived the daily window.
Raw input
1,254
1,254
Normalized
1,254
1,254
Prepared
1,254
1,254
Aligned
1,254
1,254
Invalid removed
0
A: 0 / B: 0
Duplicates removed
0
A: 0 / B: 0
Alignment drops
0
A: 0 / B: 0
Series A
Regeneron Pharmaceuticals Inc
REGN
Market cap 80.7B · 15,410 employees
Stock · 1,254 raw → 1,254 prepared
Series B
VISA Inc.
V
Market cap 583.4B
Stock · 1,254 raw → 1,254 prepared
Sign agreement
100.0%
How often both values share the same sign.
Zero crossings
30
Estimated crossover points between normalized spreads.
Slope
0.0049
Linear regression slope.
Intercept
259.5480
Linear regression intercept.
Related Extremes
Highest and Lowest Correlated
Saved 6 hours ago · ID: stock-regn-vs-stock-v-daily